Request Free Sample
×
Italy Allergy Immunotherapy Market
ID: MRFR/HC/54529-HCR
200 Pages
June 2025
Italy Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies) and By Patient Type (Pediatric, Adult, Geriatric) - Forecast to 2035
Industry Developments
In recent developments within the Italy Allergy Immunotherapy Market, companies such as Stallergenes Greer, Merck Group, and UCB S.A. have been actively involved in enhancing their product offerings, aiming to meet the rising demand for allergy treatments. The growth in this market has been fueled by increasing allergy prevalence among the Italian population, with estimates suggesting that around 30% of Italians suffer from allergic conditions. In October 2023, it was reported that Novartis AG and Regeneron Pharmaceuticals collaborated to expand their immunotherapy options, demonstrating strategic alignment to broaden distribution channels in Italy. Notably, in August 2023, Sanofi S.A. completed an acquisition of Laboratorio Farmaceutico CT, enhancing its portfolio significantly in the allergy segment. Additionally, the Italian government has emphasized the importance of R&D in immunotherapy to ensure better healthcare outcomes for allergy patients, impacting the growth trajectory of companies like Boehringer Ingelheim GmbH and GSK. Last year, Allergopharma GmbH made headlines by launching a new treatment that has garnered positive feedback from Italian healthcare practitioners, underlining the ongoing innovation in the market.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 199.5(USD Million) |
| MARKET SIZE 2024 | 214.12(USD Million) |
| MARKET SIZE 2035 | 487.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.766% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Stallergenes Greer, Merck Group, UCB S.A., Laboratorio Farmaceutico CT, Regeneron Pharmaceuticals, Novartis AG, Sanofi S.A., Boehringer Ingelheim GmbH, Medytox Inc, Anergis SA, TheraMAB, Allergopharma GmbH, HollisterStier Allergy, GSK |
| SEGMENTS COVERED | Type, Product, Indication, Patient Type |
| KEY MARKET OPPORTUNITIES | Rising allergy prevalence rates, Increasing awareness of immunotherapy, Growth in personalized treatment options, Advancements in drug delivery systems, Increased funding for allergy research |
| KEY MARKET DYNAMICS | Rising allergy prevalence, Technological advancements, Increasing awareness and education, Regulatory support and guidelines, Growth in biologics market |
| COUNTRIES COVERED | Italy |
FAQs
What is the projected market size of the Italy Allergy Immunotherapy Market in 2024?
The Italy Allergy Immunotherapy Market is expected to be valued at 214.12 million USD in 2024.
What will the market size be by the year 2035?
By 2035, the Italy Allergy Immunotherapy Market is projected to reach a value of 487.5 million USD.
What is the expected CAGR of the Italy Allergy Immunotherapy Market from 2025 to 2035?
The expected CAGR for the Italy Allergy Immunotherapy Market from 2025 to 2035 is 7.766 percent.
Which type of immunotherapy will have the highest market value in 2035?
Subcutaneous Immunotherapy is projected to have the highest market value of 194.0 million USD in 2035.
What is the market size of Sublingual Immunotherapy in 2024?
Sublingual Immunotherapy is expected to be valued at 90.0 million USD in 2024.
Who are the major players in the Italy Allergy Immunotherapy Market?
Key players in the market include Stallergenes Greer, Merck Group, UCB S.A., and Novartis AG.
What is the projected market size for Oral Immunotherapy in 2035?
Oral Immunotherapy is anticipated to reach a market size of 89.5 million USD by 2035.
What growth opportunities exist within the Italy Allergy Immunotherapy Market?
There are significant growth opportunities driven by increasing awareness and the rise in allergic conditions.
How is the market for Allergy Immunotherapy segmented by type?
The market is segmented into Subcutaneous Immunotherapy, Sublingual Immunotherapy, and Oral Immunotherapy.
What challenges does the Italy Allergy Immunotherapy Market currently face?
Challenges include limited market penetration and competition from alternative therapies.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment